The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib)

NCT03694262 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Cancer
Uterine Carcinosarcoma

Interventions

DRUG: Rucaparib
DRUG: Bevacizumab
DRUG: Atezolizumab

Sponsor

Medical College of Wisconsin

Collaborators

[object Object]
[object Object]